US Stock MarketDetailed Quotes

MBX Biosciences (MBX)

Watchlist
  • 40.530
  • -0.380-0.93%
Close Jan 16 16:00 ET
  • 41.000
  • +0.470+1.16%
Post 18:32 ET
1.82BMarket Cap-22.52P/E (TTM)

MBX Biosciences (MBX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
22.00%23.93M
30.90%21.81M
99.26%26.53M
93.12%68.19M
86.27%18.61M
79.19%19.61M
16.66M
13.31M
40.34%35.31M
9.99M
Selling and administrative expenses
62.51%4.66M
80.42%4.08M
82.08%4.12M
59.05%10.78M
49.60%3.39M
53.04%2.87M
--2.26M
--2.27M
80.05%6.78M
--2.26M
-General and administrative expense
62.51%4.66M
80.42%4.08M
82.08%4.12M
59.05%10.78M
49.60%3.39M
53.04%2.87M
--2.26M
--2.27M
80.05%6.78M
--2.26M
Research and development costs
15.07%19.27M
23.12%17.72M
102.78%22.41M
101.22%57.42M
97.01%15.22M
84.58%16.75M
--14.4M
--11.05M
33.36%28.53M
--7.73M
Operating profit
-22.00%-23.93M
-30.90%-21.81M
-99.26%-26.53M
-93.12%-68.19M
-86.27%-18.61M
-79.19%-19.61M
-16.66M
-13.31M
-40.34%-35.31M
-9.99M
Net non-operating interest income expense
57.01%2.31M
198.88%2.39M
171.14%2.65M
128.24%6.27M
163.41%3.02M
87.74%1.47M
801K
977K
137,500.00%2.75M
1.15M
Non-operating interest income
57.01%2.31M
198.88%2.39M
171.14%2.65M
128.24%6.27M
163.41%3.02M
87.74%1.47M
--801K
--977K
638.71%2.75M
--1.15M
Other net income (expense)
Income before tax
-19.16%-21.62M
-22.41%-19.41M
-93.56%-23.88M
-90.16%-61.92M
-76.25%-15.59M
-78.53%-18.14M
-15.86M
-12.34M
-24.60%-32.56M
-8.84M
Income tax
Net income
-19.16%-21.62M
-22.41%-19.41M
-93.56%-23.88M
-90.16%-61.92M
-76.25%-15.59M
-78.53%-18.14M
-15.86M
-12.34M
-24.60%-32.56M
-8.84M
Net income continuous Operations
-19.16%-21.62M
-22.41%-19.41M
-93.56%-23.88M
-90.16%-61.92M
-76.25%-15.59M
-78.53%-18.14M
---15.86M
---12.34M
-24.60%-32.56M
---8.84M
Minority interest income
Net income attributable to the parent company
-19.16%-21.62M
-22.41%-19.41M
-93.56%-23.88M
-90.16%-61.92M
-76.25%-15.59M
-78.53%-18.14M
-15.86M
-12.34M
-24.60%-32.56M
-8.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-19.16%-21.62M
-22.41%-19.41M
-93.56%-23.88M
-90.16%-61.92M
-76.25%-15.59M
-78.53%-18.14M
-15.86M
-12.34M
-24.60%-32.56M
-8.84M
Basic earnings per share
77.34%-0.63
-16.51%-0.58
-83.32%-0.71
-469.32%-5.82
-69.30%-0.47
-771.42%-2.78
-0.4978
-0.3873
-24.60%-1.0223
-0.2776
Diluted earnings per share
77.34%-0.63
-16.51%-0.58
-83.32%-0.71
-469.32%-5.82
-69.30%-0.47
-771.42%-2.78
-0.4978
-0.3873
-24.60%-1.0223
-0.2776
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 22.00%23.93M30.90%21.81M99.26%26.53M93.12%68.19M86.27%18.61M79.19%19.61M16.66M13.31M40.34%35.31M9.99M
Selling and administrative expenses 62.51%4.66M80.42%4.08M82.08%4.12M59.05%10.78M49.60%3.39M53.04%2.87M--2.26M--2.27M80.05%6.78M--2.26M
-General and administrative expense 62.51%4.66M80.42%4.08M82.08%4.12M59.05%10.78M49.60%3.39M53.04%2.87M--2.26M--2.27M80.05%6.78M--2.26M
Research and development costs 15.07%19.27M23.12%17.72M102.78%22.41M101.22%57.42M97.01%15.22M84.58%16.75M--14.4M--11.05M33.36%28.53M--7.73M
Operating profit -22.00%-23.93M-30.90%-21.81M-99.26%-26.53M-93.12%-68.19M-86.27%-18.61M-79.19%-19.61M-16.66M-13.31M-40.34%-35.31M-9.99M
Net non-operating interest income expense 57.01%2.31M198.88%2.39M171.14%2.65M128.24%6.27M163.41%3.02M87.74%1.47M801K977K137,500.00%2.75M1.15M
Non-operating interest income 57.01%2.31M198.88%2.39M171.14%2.65M128.24%6.27M163.41%3.02M87.74%1.47M--801K--977K638.71%2.75M--1.15M
Other net income (expense)
Income before tax -19.16%-21.62M-22.41%-19.41M-93.56%-23.88M-90.16%-61.92M-76.25%-15.59M-78.53%-18.14M-15.86M-12.34M-24.60%-32.56M-8.84M
Income tax
Net income -19.16%-21.62M-22.41%-19.41M-93.56%-23.88M-90.16%-61.92M-76.25%-15.59M-78.53%-18.14M-15.86M-12.34M-24.60%-32.56M-8.84M
Net income continuous Operations -19.16%-21.62M-22.41%-19.41M-93.56%-23.88M-90.16%-61.92M-76.25%-15.59M-78.53%-18.14M---15.86M---12.34M-24.60%-32.56M---8.84M
Minority interest income
Net income attributable to the parent company -19.16%-21.62M-22.41%-19.41M-93.56%-23.88M-90.16%-61.92M-76.25%-15.59M-78.53%-18.14M-15.86M-12.34M-24.60%-32.56M-8.84M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -19.16%-21.62M-22.41%-19.41M-93.56%-23.88M-90.16%-61.92M-76.25%-15.59M-78.53%-18.14M-15.86M-12.34M-24.60%-32.56M-8.84M
Basic earnings per share 77.34%-0.63-16.51%-0.58-83.32%-0.71-469.32%-5.82-69.30%-0.47-771.42%-2.78-0.4978-0.3873-24.60%-1.0223-0.2776
Diluted earnings per share 77.34%-0.63-16.51%-0.58-83.32%-0.71-469.32%-5.82-69.30%-0.47-771.42%-2.78-0.4978-0.3873-24.60%-1.0223-0.2776
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More